Skip to main content

Clear Harbor Asset Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1511857 Stamford, CT

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,745,139
-$3,657,321 QoQ
Shares Held
7,610
-30.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#397
of 1,322 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Dec 31, 2023
CallValue
$351,316
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Clear Harbor Asset Management, LLC holds $6,083,006 across 9 Biotechnology names. REGN ranks #1 (78.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
7,610 $4,745,139

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,745,139 7,610
2026-03-31 $8,402,460 10,875
2025-12-31 $8,154,034 10,564
2025-09-30 $5,980,865 10,637
2025-06-30 $4,419,975 8,419
2025-03-31 $4,314,666 6,803
2024-12-31 $3,861,540 5,421
2024-09-30 $2,538,744 2,415
2024-06-30 $2,516,165 2,394
2024-03-31 $2,298,426 2,388
2023-12-31 $351,316 400
2023-12-31 $2,078,034 2,366
2023-09-30 $1,852,482 2,251
2023-06-30 $1,623,181 2,259
2023-03-31 $1,847,114 2,248
2022-12-31 $1,614,694 2,238
2022-09-30 $1,498,981 2,176
2022-06-30 $1,298,121 2,196
2022-03-31 $1,528,142 2,188
2021-12-31 $1,225,780 1,941
2021-09-30 $1,166,181 1,927
2021-06-30 $1,002,020 1,794
2021-03-31 $722,011 1,526